Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial

Controlled Trial ◽

Once Daily ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Metformin Monotherapy

A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc18-1760 ◽

2019 ◽

Vol 42 (3) ◽

pp. 450-456 ◽

Cited By ~ 18

Author(s):

Maya Fayfman ◽

Rodolfo J. Galindo ◽

Daniel J. Rubin ◽

Dara L. Mize ◽

Isabel Anzola ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

General Medicine ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Inpatient Management

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes

Diabetic Medicine ◽

10.1111/dme.12828 ◽

2015 ◽

Vol 33 (2) ◽

pp. 224-230 ◽

Cited By ~ 36

Author(s):

M. A. Bethel ◽

P. Harrison ◽

H. Sourij ◽

Y. Sun ◽

L. Tucker ◽

...

Keyword(s):

Type 2 Diabetes ◽

Platelet Reactivity ◽

Controlled Trial ◽

Once Daily ◽

Randomized Controlled ◽

Daily Aspirin

A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes

The Journal of Clinical Pharmacology ◽

10.1002/jcph.483 ◽

2015 ◽

Vol 55 (7) ◽

pp. 831-838 ◽

Cited By ~ 2

Author(s):

Yuichiro Inoue ◽

Akinobu Nakamura ◽

Yoshinobu Kondo ◽

Kumiko Hamano ◽

Shinobu Satoh ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Insulin Detemir ◽

Controlled Trial ◽

Daily Injection ◽

Once Daily ◽

Liraglutide Hospital Discharge Trial: A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide versus Glargine Insulin for the Management of Patients with Type 2 Diabetes After Hospital Discharge

Diabetes Obesity and Metabolism ◽

10.1111/dom.14347 ◽

2021 ◽

Author(s):

Francisco J Pasquel ◽

Maria A Urrutia ◽

Saumeth Cardona ◽

K. Walkiria Zamudio Coronado ◽

Bonnie Albury ◽

...

Keyword(s):

Type 2 Diabetes ◽

Hospital Discharge ◽

Controlled Trial ◽

Glargine Insulin ◽

Safety And Efficacy ◽

A randomized controlled trial protocol of the cardiovascular safety and efficacy of liraglutide in the treatment of type 2 diabetes

Medicine ◽

10.1097/md.0000000000023948 ◽

2021 ◽

Vol 100 (3) ◽

pp. e23948

Author(s):

Ying Liang ◽

Hua Meng ◽

Ruiyu Li ◽

Jianbin Yang ◽

Jingchao Jia ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Trial Protocol ◽

Cardiovascular Safety ◽

Safety And Efficacy ◽

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2008.03.018 ◽

2008 ◽

Vol 81 (2) ◽

pp. 161-168 ◽

Cited By ~ 79

Author(s):

Y. Seino ◽

M.F. Rasmussen ◽

M. Zdravkovic ◽

K. Kaku

Keyword(s):

Type 2 Diabetes ◽

Weight Gain ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Once Daily ◽

Randomized Controlled ◽

Dose Dependent

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

BMC Endocrine Disorders ◽

10.1186/1472-6823-14-17 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 15

Author(s):

Judith L White ◽

Patricia Buchanan ◽

Jia Li ◽

Robert Frederich

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Metformin Monotherapy ◽

Inadequate Glycemic Control

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0163350 ◽

2016 ◽

Vol 11 (10) ◽

pp. e0163350 ◽

Cited By ~ 13

Author(s):

Ajay Kumar ◽

Edward Franek ◽

Jonathan Wise ◽

Marcus Niemeyer ◽

Henriette Mersebach ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Controlled Trial ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Once Daily ◽

Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial

Diabetes Technology & Therapeutics ◽

10.1089/dia.2009.0062 ◽

2009 ◽

Vol 11 (11) ◽

pp. 697-705 ◽

Cited By ~ 30

Author(s):

Julio Rosenstock ◽

William T. Cefalu ◽

Priscilla A. Hollander ◽

Sol S. Klioze ◽

Joann Reis ◽

...

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Controlled Trial ◽

Safety And Efficacy ◽

Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

Diabetes & Metabolism Journal ◽

10.4093/dmj.2019.0093 ◽

2020 ◽

Vol 44 (4) ◽

pp. 532 ◽

Cited By ~ 1

Author(s):

Kyu Yong Cho ◽

Akinobu Nakamura ◽

Chiho Oba-Yamamoto ◽

Kazuhisa Tsuchida ◽

Shingo Yanagiya ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Insulin Degludec ◽

Once Daily ◽

Postprandial Glycemia ◽